Tag: TRxA
-

C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes […]

